Evolus, Inc. Common Stock (EOLS) — Analysis Summary
Evolus, Inc. Common Stock (EOLS) has a market cap of $444.52M with year-over-year revenue growth of +11.6%. Net margin stands at -17.4%. The stock trades at a P/E ratio of -10.2.
Key Takeaways
- Revenue changed +11.6% year-over-year
- Net margin of -17.4%
- P/E ratio of -10.2
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, EOLS posted revenue growth of +11.6% and trades at a P/E of -10.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.